Registered Nurse in Gainesboro, TN Accepting Medicare
6 Registered Nurse nurses found. Showing 1 - 6
 Kelsie Stafford, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 N Murray St, Gainesboro, TN 38562 Phone: 931-268-0218 |
Kursten Mckenzie Roop, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 N Murray St, Gainesboro, TN 38562 Phone: 931-268-0218 Fax: 931-268-0289 |
Patricia L Conlan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 N Murray St, Gainesboro, TN 38562 Phone: 931-268-0218 |
Candi Denise Holland, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 N Murray St, Gainesboro, TN 38562 Phone: 931-268-0218 Fax: 931-268-0872 |
Mrs. Linda Ruth Gaumont, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 744 School Dr, Tn Dept Of Health, Gainesboro, TN 38562 Phone: 931-268-0218 |
Ms. Kendra Diann Maynard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 N Murray St, Gainesboro, TN 38562 Phone: 931-268-0218 Fax: 931-268-0872 |
News Archive
Novel vaccine strain with high efficacy against tuberculosis
Tuberculosis remains a major global health threat. Although more than 3 billion doses of the BCG vaccine have been administered to fight tuberculosis, the ability of the BCG vaccine to protect adults is very limited, as is its efficacy against newly emerging isolates.
Small differences in specific genetic variant could alter nicotine consumption
Nicotine is an addictive substance and genetic factors are known to play a role in smoking behaviors. Recently, a team of researchers at Penn State and the University of Colorado determined how small differences in a particular region of the mouse genome can alter nicotine consumption.
Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis
Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.
Presbia unveils implantable micro-lens treatment for presbyopia
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.
› Verified 7 days ago
Registered Nurse
Nurse Practitioner
Licensed Practical Nurse